Rocky Mountain Voice

Menu

Tag: Big Pharma

RFK Jr.: It’s time for real vaccine accountability—and HHS just took the first step
No Comments
Approved, Commentary, National, The Wall Street Journal

RFK Jr.: It’s time for real vaccine accountability—and HHS just took the first step

By Robert F. Kennedy Jr. | Commentary, Wall Street Journal We’re reconstituting an advisory committee to avoid conflicts of interest. Vaccines have become a divisive issue in American politics, but there is one thing all parties can agree on: The U.S. faces a crisis of public trust. Whether toward health agencies, pharmaceutical companies or vaccines themselves, public confidence is waning. Some would try to explain this away by blaming misinformation or antiscience attitudes. To do so, however, ignores a history of conflicts of interest, persecution of dissidents, a lack of curiosity, and skewed science that has plagued the vaccine regulatory apparatus for decades.That is why, under my direction, the U.S. Department of Health and Human Services is putting the restoration of publi...
Read More
Joondeph: Make prescription drugs affordable again
No Comments
American Thinker, Approved, Commentary, National

Joondeph: Make prescription drugs affordable again

By Dr. Brian C. Joondeph | Commentary, American Thinker Last week, President Donald Trump grabbed his Sharpie and signed an executive order to tackle the sky-high prescription drug prices in the U.S. The plan? A “Most Favored Nation” (MFN) pricing model that aligns U.S. drug costs with those of other countries.  Sound familiar? Trump tried this during his first term, but the courts rejected it, and Biden hit the 'undo' button. Here’s the lowdown on why Trump is back at it, what’s at stake, and whether this bold move will stick. Trump has promised cheaper drugs since his campaign days, alongside crowd-pleasers like building the wall and draining the swamp. Americans are fed up, paying nearly three times more for medications than people in other wealthy c...
Read More
Federal judge dismisses drug company’s suit challenging Colorado prescription affordability board
No Comments
Approved, State, The Colorado Sun

Federal judge dismisses drug company’s suit challenging Colorado prescription affordability board

By John Ingold | The Colorado Sun A federal judge tossed out a lawsuit filed by the pharmaceutical company Amgen challenging the authority of a Colorado board that seeks to rein in high-priced prescription drugs. U.S. District Court Judge Nina Y. Wang ruled Friday that Amgen had not shown it has or likely will suffer harm from the board’s actions. As a result, she granted the state’s motion to dismiss the lawsuit, but she did so “without prejudice” — meaning Amgen could sue again if it can later show harm. “The economic injuries alleged by Amgen are too speculative and too attenuated to support standing in this case,” Wang wrote in her order. The case involved a relatively obscure body known as the Colorado Prescription Drug Affordability Board, or PDAB, which has the authority...
Read More
Profit or patients? The 340B fight that could close Colorado hospitals
No Comments
Approved, Rocky Mountain Voice, State, Top Stories

Profit or patients? The 340B fight that could close Colorado hospitals

By Jen Schumann | Contributing Writer, Rocky Mountain Voice If Senate Bill 25-071 fails, Julie Lonborg says her neighbor could end up driving from Lone Tree to Thornton just to pick up a single prescription. That’s not some theoretical what-if. It’s a glimpse into what hospital leaders say is already unfolding in Colorado, especially for patients in rural communities who depend on access to affordable medication through the federal 340B drug discount program. SB25-071, known as the Colorado 340B Contract Pharmacy Protection Act, aims to stop pharmaceutical manufacturers from placing limits on where and how hospitals dispense discounted drugs to vulnerable patients.  Supporters say it’s the only thing standing between local hospitals and a set of restrictions from out-of-state...
Read More
Democrat critics of Robert F. Kennedy Jr. on the big pharma, healthcare dole for millions of dollars
No Comments
Approved, Breitbart, National

Democrat critics of Robert F. Kennedy Jr. on the big pharma, healthcare dole for millions of dollars

By Sean Moran | Breitbart During Robert F. Kennedy Jr.’s confirmation hearing on Wednesday, Senate Democrats criticized the healthcare nominee for chasing money and influence, while they have received millions of dollars from the healthcare industry. Sen. Ron Wyden said that Kennedy, who Trump nominated to be his Health and Human Services Department Secretary, is “someone who chases money and influence wherever they lead, even if that may mean the tragic death of children and other vulnerable people.” Although Wyden attacked Kennedy for allegedly chasing “money and influence,” it appears that Wyden has raised significant sums from the healthcare industry, which has a vested stake in the potential confirmation of Kennedy. READ THE FULL STORY AT BREITBART
Read More
Pharma giant seeks to join lawsuit against FDA over weight loss drugs 
No Comments
Approved, National, THE HILL

Pharma giant seeks to join lawsuit against FDA over weight loss drugs 

By Joseph Choi  | The Hill Eli Lilly is seeking to end a lawsuit filed by a pharmacy trade group against the Food and Drug Administration (FDA) by joining as a defendant, stating it wants to end the “entitlement” some pharmacies have practiced in mass-marketing copies of its highly popular GLP-1 medications. The lawsuit in question concerns the FDA’s decision to officially declare the shortages of Mounjaro and Zepbound, both forms of the GLP-1 drug tirzepatide, to be over in October. The suit was filed by the Outsourcing Facilities Association (OFA), a trade group that represents 503B compounding pharmacies, seeking to overturn the FDA’s decision. After the suit was filed, the FDA temporarily paused to reconsider the declaration to end the shortage but ultimately reaffirmed its de...
Read More
Harris, Biden talk big on ‘Big Pharma’, but have accepted combined $11M in campaign donations since 1990
No Comments
Approved, National, The Daily Signal

Harris, Biden talk big on ‘Big Pharma’, but have accepted combined $11M in campaign donations since 1990

By Elizabeth Troutman Mitchell  | Commentary, The Daily Signal President Joe Biden and Vice President Kamala Harris slammed Big Pharma for “inflating the price of lifesaving medications” in a speech Thursday in Largo, Maryland. But Biden and Harris’ congressional campaigns received $9 million and $2 million, respectively, from 1990-2024. “Folks, this is a fight all of us have been fighting for a long time,” Biden said. “Thinking about Big Pharma, we pay more for prescription drugs, it’s not hyperbole, we pay more for prescription drugs than any advanced nation in the world.” Despite Biden and Harris’ strong anti-Big Pharma rhetoric, Biden was the top congressional recipient of donations from pharmaceuticals and health care products from 1990-2024, accepting more than $9 ...
Read More